AM-36对鼠液压颅脑伤神经保护作用的初步研究
被引量:3
摘要
AM-36是一种新型的电压依赖和应用依赖型Na^+通道阻滞剂,有作者在脑缺血性卒中的动物模型中证实AM-36具有明确的神经保护作用,本研究首次在颅脑外伤(TBI)动物模型中使用AM-36,对这种新型的Na^+通道阻滞剂在TBI中的神经保护作用进行初步研究。
出处
《中华神经外科杂志》
CSCD
北大核心
2006年第2期89-92,共4页
Chinese Journal of Neurosurgery
参考文献15
-
1Callaway JK. Investigation of AM-36: A novel neuroprotective agent. Clin and Exp Pharm and Physio,2001,28:913-918.
-
2Callaway JK, Lawrence AJ, Jarrott B. AM-36,a novel neuroprotective agent, profoundly reduces reactive oxygen species formation and dopamine release in the striatum of conscious rats after endothelin-1-induced middle cerebral artery occlusion. Neuropharmacology, 2003, 44: 787-800.
-
3Callaway JK, Castillo-Melendez M, Giardian SF, et al. Sodium channel blocking activity of AM-36 and sipatrigine (BW619C89):in vitro and in vivo evidence. Neuropharmacology, 2004, 47:146-155.
-
4Callaway JK, Knight MJ, Watkins DJ, et al. Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats. Stroke, 1999, 30: 2704-2712.
-
5Maas AI, Dearden M, Servadei F, et al. Current recommendations for neurotrauma. Current Opinion in Critical Care, 2000, 6:281-292.
-
6Marshall LF. Head injury: Recent past, present, and future.Neurosurgery, 2000, 47: 546-561.
-
7Bullock R, Zauner A, Woodward JJ, et al. Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg, 1998, 89: 507-518.
-
8Leker RR, Shohami E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Rev, 2002, 39: 55-73.
-
9Taylor CP, Meldrum BS. Sodium channels as targets for neuroprotective drugs. Trends in Pharmacological Sciences, 1995,16: 309-316.
-
10Bonoczk P, Gulyas B, Adam-Vizi V, et al. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.Brain Res Bull, 2000, 53: 245-254.
二级参考文献27
-
1Melena J, Chidlow G, Osborne NN. Blockade of voltage-sensitive Na^+ channels by the 5 - HT1A receptor agonlst 8 - OH - DPAT:possible significance for neuroprotection. Eur. J. Pharmacol. 2000,406(3) :319 - 324.
-
2Kline AE, Yu J, Massucci JL, et ill. Protective effects of the 5-HTIA receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin against traumatic brain injury-induced cognitive deficits and neuropathology in adult male rots. Neurosci Lett. 2002 ,333(3): 179- 182.
-
3Nelson RM, Lambert DG, Richard GA, et al. Pharmacoloty of ischemia-induced glutamate efflux from rat cerebral cortex in vitro. Brain Res.2003,964(1):1 -8.
-
4Chatton JY, Shimamoto K, Magistretti PJ. Effects of glial glutamate transporter inhibitors on intracellular Na^+ in mouse astrocytes. Brain Res, 2001,893(1-2) :46 - 52.
-
5Ravens U, Himmel HM . Drugs preventing Na^+ and Ca^2+ overload. Pharmacol Res. 1999 ,39(3) : 167 - 174.
-
6Tanaka K, Ito D, Suzuki S, et al. A novel voltage-sensitive Na+ and Ca2+ channel blocker, NS- 7, prevents suppression of cyclic AMP-dependent protein kinase and reduces infarct area in the acute phase of cerebral ischemia in rat. Brain Res. 2002,924(1):98-108.
-
7Wolf J, Stys PK., Lusardi T, et al. Traumatic axonal injury induces calcium influx modulated by tetrodotoxin - sensitive sodium channels. J Neuroscience. 2001, 21(6) :1923 - 1930.
-
8Stys PK. White matter injury mechanisms. Curr Mol Med. 2004 , 4 (2):113-130.
-
9Callaway JK, Castillo- Melendez M, Giardina SF, et al. Sodium channel blocking activity of AM - 36 and 8ipatrigine (BW619C89) : in vitro and in vivo evidence. Neuropharmacology. 2004,47(1) : 146-155.
-
10Taylor CP, Meldrum BS. Sodium channels as targets for neuropretective drugs. Trends in Pharmacological Sciences. 1995,16(9) :309 - 316.
共引文献26
-
1黄云柯,黄熙.脑外伤急性氧化损伤时间过程:问题与对策[J].中南大学学报(医学版),2014,39(2):195-198. 被引量:5
-
2周新民,冯俊,郑叶平,项明珍.充氧器治疗颅脑损伤脑缺氧55例疗效观察[J].浙江实用医学,2006,11(1):36-37.
-
3吴明,雷万生,朱炯明,祝斐,金卫星,谢联斌.雪莲黄酮对大鼠创伤性脑水肿的治疗作用及其机制的初步研究[J].中国临床神经外科杂志,2006,11(3):157-159. 被引量:3
-
4毛青,丁勇,陆兆丰,罗其中,江基尧.AM-36对大鼠液压脑损伤的神经保护作用[J].中华创伤杂志,2006,22(10):758-762. 被引量:2
-
5施辉,吴惠毅,周辉,孙伟晔,刘希光,李爱民,陈覃.重型颅脑损伤患者血浆8-表氧前列腺素F_(2α)水平及抗氧化剂疗效评价[J].中华神经医学杂志,2006,5(12):1240-1242. 被引量:13
-
6田鑫,江基尧,徐纪文,王桂松,邱永明,殷玉华,梁玉敏,包映晖.早期应用马来酸桂哌齐特救治急性中重型颅脑损伤患者的临床研究[J].中华神经外科杂志,2007,23(10):775-777. 被引量:1
-
7朱志安,楚胜华,肖波.促红细胞生成素对颅脑损伤后线粒体ATP酶活性及自由基代谢的影响[J].中华神经医学杂志,2008,7(9):903-905. 被引量:2
-
8毛青,贾锋,张晓华,邱永明,金文晓,葛建伟,罗其中,江基尧.大鼠颅脑损伤后钠通道α亚单位1.3(Nav1.3)在海马中的表达[J].中国微侵袭神经外科杂志,2009,14(2):77-80.
-
9毛青,贾锋,邱永明,张晓华,葛建伟,余丰平,罗其中,江基尧.颅脑创伤后大鼠海马Nav 1.1和Nav 1.2的异常表达[J].中华创伤杂志,2009,25(4):309-313. 被引量:1
-
10毛青,贾锋,张晓华,邱永明,葛建伟,吴日乐,张兴福,罗其中,江基尧.大鼠颅脑创伤后Na_V1.6在海马的表达[J].上海交通大学学报(医学版),2009,29(4):399-403. 被引量:1
同被引文献64
-
1毛青,江基尧.颅脑外伤后继发性脑损害发病机制的研究进展[J].中华神经医学杂志,2005,4(2):200-202. 被引量:25
-
2毛青,江基尧.抑制Na^+内流与神经保护作用[J].国外医学(神经病学.神经外科学分册),2005,32(1):15-18. 被引量:5
-
3张赛,李建伟,只达石,胡群亮,孙洪涛.外源性镁离子对重型颅脑创伤患者的治疗作用[J].中华神经外科杂志,2006,22(2):76-78. 被引量:26
-
4杜显刚,官鹏,陈雪梅,张林,李明远,谭志巍,王亚琴,Yunjuan Sun.大鼠脑外伤后大脑皮质脑红蛋白的定量研究[J].中国法医学杂志,2006,21(3):129-132. 被引量:17
-
5陈罡,杭春华,冯东侠,徐伟东,周新民,那汉荣,高恒.人脑外伤后皮层基质金属蛋白酶9的表达:定量、定位和时相[J].中国实用神经疾病杂志,2006,9(4):3-5. 被引量:3
-
6陈峻严,黄金钟,黄种心,邱建龙,周培萱.颅脑外伤后局部脑组织HSP70基因的表达[J].中华创伤杂志,2006,22(8):623-624. 被引量:8
-
7何敏慧,马岳峰,狄海波.外伤性脑损伤与继发性垂体功能减退[J].中华急诊医学杂志,2006,15(8):765-766. 被引量:5
-
8孙治坤,陈生弟.促红细胞生成素的神经保护功能[J].国际神经病学神经外科学杂志,2007,34(2):141-144. 被引量:2
-
9Engstrom M, Schott U, Nordstrom CH,et al. Increased lactate levels impair the coagulation system--a potential contributing factor to progressive hemorrhage after traumatic brain injury. [ J ]. J Neurosurg Anesthesiol,2006,18 ( 3 ) : 200-204.
-
10Lescot T, Degos V,Zouaoui A,et al. Opposed effects of hypertonic saline on contusions and noncontused brain tissue in patients with severe traumatic brain injury[ J]. Crit Care Med,2006,34(12) : 3029-3033.
引证文献3
-
1奚才华,胡锦,周良辅.颅脑外伤后的靶向神经保护[J].国际神经病学神经外科学杂志,2008,35(3):221-224.
-
2李冰,闫华,只达石,刘暌.颅脑创伤研究的回顾(2006~2007年)[J].医学综述,2008,14(22):3441-3444. 被引量:2
-
3毛青,贾锋,张晓华,邱永明,葛建伟,吴日乐,张兴福,罗其中,江基尧.大鼠颅脑创伤后Na_V1.6在海马的表达[J].上海交通大学学报(医学版),2009,29(4):399-403. 被引量:1
二级引证文献3
-
1闫华,徐鹏,薛静,侯永新,段世博,李冰,张国斌,刘暌,只达石.颅脑创伤后血清抗脑抗体变化及免疫抑制研究[J].中华神经外科杂志,2010,26(2):155-158. 被引量:10
-
2任丽,王玉凯,方燕南.电针治疗对大鼠脑缺血后电压门控型钠通道Na(v)1.6表达的影响[J].中国脑血管病杂志,2010,7(12):648-652. 被引量:3
-
3郝江,罗积慎,何毅,翁奇,刘军,杨明浩,张萍.右美托咪啶在颅脑创伤镇静镇痛中的应用[J].中华急诊医学杂志,2011,20(12):1255-1258. 被引量:13
-
1赵钢,粟秀初.脑缺血性卒中动物模型[J].卒中与神经疾病,1996,3(2):99-100. 被引量:4
-
2杨晓华,张玉凤,刘俊萍,杨华.Ca^(++)通道阻滞剂治疗缺血性脑血管病的疗效分析[J].黑龙江医学,1997,0(3):18-18.
-
3江云.遗传易感性与缺血性卒中[J].医学研究生学报,2001,14(6):542-543. 被引量:1
-
4神经病学与精神病学[J].中国临床新医学,1994,7(4):247-250.
-
5彭桂茹,陈平,张莹.脑缺血性卒中病人的体感诱发电位临床应用价值[J].天津医药,2001,29(6):366-367.
-
6胡建芳,尤劲松,汪峰,黄培新.钠离子通道与缺血性脑卒中的关系[J].临床神经病学杂志,2007,20(2):154-156.
-
7温宏峰,李继来,王培福,杜继臣.血栓弹力图评价缺血性脑血管病患者服用不同小剂量阿司匹林疗效[J].中风与神经疾病杂志,2013,30(6):554-555. 被引量:3
-
8陈宝谭,宋君平.进展性脑缺血性卒中348例临床分析[J].中国医药指南,2011,9(34):68-69. 被引量:1
-
9吴兴萍,郭露萍,黄娟,陈振谦.缺血性脑卒中患者颈动脉超声与颅底大动脉经颅多普勒的改变[J].实用临床医学(江西),2006,7(4):118-119. 被引量:7
-
10本刊.阿托伐他汀40~80mg有效降低卒中/TIA患者颈动脉斑块易损性[J].中国循证心血管医学杂志,2015,7(4):481-481.